(Q37739036)

22 August 2017

1 reference

title

Assessing women at high risk of breast cancer: a review of risk assessment models (English)

1 reference

22 August 2017

1 reference

risk assessment model

1 reference

4

1 reference

22 August 2017

Eitan Amir

1

0 references

Boštjan Šeruga

series ordinal

3

object named as

Bostjan Seruga

1 reference

22 August 2017

Orit C Freedman

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

28 April 2010

1 reference

Journal of the National Cancer Institute

22 August 2017

published in

1 reference

22 August 2017

volume

102

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

680-691

1 reference

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Genome-wide association study identifies novel breast cancer susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Ten genes for inherited breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Clinical management of BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Pre-test prediction models of BRCA1 or BRCA2 mutation in breast/ovarian families attending familial cancer clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A breast cancer prediction model incorporating familial and personal risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Assessing BRCA carrier probabilities in extended families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Optimal selection of individuals for BRCA mutation testing: a comparison of available methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Evaluation of models to predict BRCA germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Validity of models for predicting BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Selecting a BRCA risk assessment model for use in a familial cancer clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Limited family structure and BRCA gene mutation status in single cases of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Paternal relatives and family history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Application of breast cancer risk prediction models in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Central obesity and breast cancer risk: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Calcium plus vitamin D supplementation and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Breast cancer risk-assessment models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Proportion of breast cancer cases in the United States explained by well-established risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Validation of the Gail et al. model for predicting individual breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Validation studies for models projecting the risk of invasive and total breast cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Validation of a breast cancer risk assessment model in women with a positive family history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Assessment of the accuracy of the Gail model in women with atypical hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Determining Carrier Probabilities for Breast Cancer–Susceptibility Genes BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Novel use of single X-ray absorptiometry for measuring breast density

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A common coding variant in CASP8 is associated with breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

Localization of the gene for Cowden disease to chromosome 10q22–23

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ088

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJQ088

1 reference

release_xxrumuahpvfhznvpaceao54oae

22 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xxrumuahpvfhznvpaceao54oae

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference